ArticleBMJ open2021

Study protocol for a phase II randomised, double-blind, placebo-controlled trial of perampanel as an antiepileptogenic treatment following acute stroke.

John-Paul Nicolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.